Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjogren's syndrome

被引：3
作者：
Vincent, Fabien B. [1 ,2 ]
Lang, Tali [1 ,3 ]
Kandane-Rathnayake, Rangi [1 ]
Downie-Doyle, Sarah [4 ]
Morand, Eric F. [1 ]
Rischmueller, Maureen [4 ]
机构：
[1] Monash Univ, Sch Clin Sci, Monash Hlth, Rheumatol Res Grp,Ctr Inflammatory Dis, Clayton, Vic 3168, Australia
[2] Monash Univ, Cent Clin Sch, AMREP, Dept Immunol & Pathol, 89 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Cabrini Inst, Szalmuk Family Dept Med Oncol, Malvern, Vic 3144, Australia
[4] Univ Adelaide, Discipline Med, Queen Elizabeth Hosp, Rheumatol Dept, Adelaide, SA 5011, Australia
来源：
JOINT BONE SPINE | 2019年 / 86卷 / 03期
关键词：
Biomarker; Macrophage migration inhibitory factor (MIF); Primary Sjogren's syndrome (pSS); SEVERITY;
D O I：
10.1016/j.jbspin.2018.07.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：393 / 395
页数：3
相关论文
共 8 条
  • [1] Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis
    Ayoub, Sally
    Hickey, Michael J.
    Morand, Eric F.
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (02): : 98 - 105
  • [2] Brown FG, 2002, J AM SOC NEPHROL, V13, pS7
  • [3] MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
    Lang, Tali
    Foote, Andrew
    Lee, Jacinta P. W.
    Morand, Eric F.
    Harris, James
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [4] Advances in understanding the pathogenesis of primary Sjogren's syndrome
    Nocturne, Gaetane
    Mariette, Xavier
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (09) : 544 - 556
  • [5] Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
    Seror, Raphaele
    Bootsma, Hendrika
    Saraux, Alain
    Bowman, Simon J.
    Theander, Eike
    Brun, Johan G.
    Baron, Gabriel
    Le Guern, Veronique
    Devauchelle-Pensec, Valerie
    Ramos-Casals, Manel
    Valim, Valeria
    Doerner, Thomas
    Tzioufas, Athanasios
    Gottenberg, Jacques -Eric
    Laque, Roser Solans
    Mandl, Thomas
    Hachulla, Eric
    Sivils, Kathy L.
    Ng, Wan-Fai
    Fauchais, Anne-Laure
    Bombardieri, Stefano
    Priori, Roberta
    Bartoloni, Elena
    Goeb, Vincent
    Praprotnik, Sonja
    Sumida, Takayuki
    Nishiyama, Sumusu
    Caporali, Roberto
    Kruize, Aike A.
    Vollenweider, Cristina
    Ravaud, Philippe
    Meiners, Petra
    Brito-Zeron, Pilar
    Vitali, Claudio
    Mariette, Xavier
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (02) : 382 - 389
  • [6] Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus
    Sreih, Antoine
    Ezzeddine, Rana
    Leng, Lin
    LaChance, Avery
    Yu, Geraldine
    Mizue, Yuka
    Subrahmanyan, Lakshman
    Pons-Estel, Bernardo A.
    Abelson, Anna-Karin
    Gunnarsson, Iva
    Svenungsson, Elisabet
    Cavett, Joshua
    Glenn, Stuart
    Zhang, Lin
    Montgomery, Ruth
    Perl, Andras
    Salmon, Jane
    Alarcon-Riquelme, Marta E.
    Harley, John B.
    Bucala, Richard
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 3942 - 3951
  • [7] Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
    Vitali, C
    Bombardieri, S
    Jonsson, R
    Moutsopoulos, HM
    Alexander, EL
    Carsons, SE
    Daniels, TE
    Fox, PC
    Fox, RI
    Kassan, SS
    Pillemer, SR
    Talal, N
    Weisman, MH
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (06) : 554 - 558
  • [8] Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjogren's syndrome
    Willeke, Peter
    Gaubitz, Markus
    Schotte, Heiko
    Maaser, Christian
    Domschke, Wolfram
    Schlueter, Bernhard
    Becker, Heidemarie
    [J]. ARTHRITIS RESEARCH & THERAPY, 2007, 9 (02)
1